NevaBio
Immunotherapy for Cancer Prevention
Health Tech & Life Sciences
Non Active, Apr 2021 ceased to operate
Company Overview
Snapshot
Founded in September 2017, NevaBio operates with 1–10 employees. The company ceased operations in April 2021.
Business overview
NevaBio is a Health Tech & Life Sciences company focused on the discovery and development of anticancer immunotherapy treatments. The company's core technology aims to provide immunotherapy solutions for cancer prevention, primarily serving the pharmaceutical and life sciences industries.
Company Intelligence Q&A
- What is NevaBio's primary focus?
- NevaBio is engaged in the discovery and development of anticancer immunotherapy treatments, primarily focused on cancer prevention.
- When was NevaBio founded?
- NevaBio was founded in September 2017.
- What is the operational status of NevaBio?
- NevaBio ceased to operate in April 2021.
- What sector does NevaBio operate in?
- NevaBio operates within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Drugs Discovery & Development.
- Who are the co-CEOs of NevaBio?
- Rinat Rotem-Yehudar and Moti Hacham are the co-CEOs of NevaBio.